Plerixafor Impurity 29 | CAS 170161-27-0 - Request Quote
Plerixafor Impurity 29
| SZ CAT No: | SZ-P070046 |
| CAS No | 170161-27-0 |
| Mol.F. | C25H48N4O6 |
| Mol.Wt. | 500.7 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Plerixafor Impurity 29 is chemically Tri-tert-butyl 1,4,8,11-tetraazacyclotetradecane-1,4,8-tricarboxylate. Plerixafor Impurity 29 is supplied with detailed characterization data compliant with regulatory guideline. Plerixafor Impurity 29 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Plerixafor.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 170161-27-0
Purchase 170161-27-0
Order 170161-27-0
Enquire 170161-27-0
price of 170161-27-0
170161-27-0 Supplier
170161-27-0 Manufacturer
170161-27-0 Exporter
buy high quality Plerixafor Impurity 29
Purchase Plerixafor Impurity 29
Plerixafor Impurity 29 suppliers
Plerixafor Impurity 29 manufacturers
Plerixafor Impurity 29 price
Order Plerixafor Impurity 29
Enquire Plerixafor Impurity 29
Plerixafor Impurity 29 cost
Plerixafor Impurity 29 Supplier
Plerixafor Impurity 29 Distributor
Plerixafor Impurity 29 for Method Validation
Plerixafor Reference Standard
Plerixafor Impurity 29 for ANDA Filing
Plerixafor Impurity 29 for Forced Degradation Studies
Plerixafor Impurity 29 Identification Standards
Plerixafor Impurity 29 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


